Account Executive, DACH

Regional Sales Manager, West Coast

1910 Genetics

20n Bio

3DBio Therapeutics

3T Biosciences

4D Molecular Therapeutics

64x Bio

8Biomed

A-Alpha Bio

A2 Biotherapeutics

AavantiBio

AB Studio

Abalone Bio

Abata Therapeutics

Abeona Therapeutics

Abintus Bio

Abiosciences

Absci

Accelevir Diagnostics

Accent Therapeutics

ACELYRIN

Acepodia

Achieve Life Sciences

Acrivon Therapeutics

Acrotech Biopharma

Acutis Diagnostics

Adagio Therapeutics

Adaptive Phage Therapeutics

Adcentrx Therapeutics

Adicet Bio

Aditum Bio

adMare BioInnovations

Admera Health

Adverum Biotechnologies

adyn

Aeglea BioTherapeutics

Aether Bio

Affini-T Therapeutics

Affinia Therapeutics

Affinivax

AgBiome

Agena Bioscience

Akero Therapeutics

Akouos

Alamar Biosciences

Alector

AlivaMab Discovery Services

Alkahest

Alladapt Immunotherapeutics

Allakos

Allarta Life Science

Allay Therapeutics

AlloVir

Alloy Therapeutics

AllStripes

Alltrna

Alpine Immune Sciences

Altavant Sciences

Altis Biosystems

Alto Neuroscience

AltPep

Alumis

Alveo Technologies

ALX Oncology

Alzheon

Ambagon Therapeutics

Amberstone Biosciences

Ambys Medicines

Amylyx

AN2 Therapeutics

Anagenex

Andes

Angiocrine Bioscience

AnHeart Therapeutics

Annexon Biosciences

Antheia

Apollomics

Appia Bio

Applied Molecular Transport

Apriori Bio (Flagship)

Aptevo Therapeutics

Apton Biosystems

Aptose Biosciences

Aquinnah Pharmaceuticals

Arbor Biotechnologies

Arcadia Science

Arcellx

Arcturus Therapeutics

Arcutis Biotherapeutics

Arima Genomics

Ark Biotech

Arkuda Therapeutics

Armata Pharmaceuticals

Aro Biotherapeutics

Arpeggio Biosciences

Arrakis Therapeutics

Arranta Bio

ArsenalBio

Artisan Bio

Artiva Biotherapeutics

Aruvant

Ultivue is developing solutions for researchers to uncover the spatial biology of cells. Spatial phenomics involves mining tissue images in their own context to identify spatial patterns that are linked to clinical outcomes. To mine tissue images, Ultivue created their InSituPlex technology that creates a linear relationship between biomarker abundance and staining intensity and avoids tedious calibration and ambiguous spectral unmixing. Unlimited numbers of biomarkers can be used in the assay system and can be co-localized with up to 12 markers, enabling the efficient testing of several hypotheses quickly and robustly. Ultivue’s technology has been used for diverse applications, including imaging of the tumor microenvironment. 

<p>Ultivue is developing solutions for researchers to uncover the spatial biology of cells. Spatial phenomics involves mining tissue images in their own context to identify spatial patterns that are linked to clinical outcomes. To mine tissue images, Ultivue created their InSituPlex technology that creates a linear relationship between biomarker abundance and staining intensity and avoids tedious calibration and ambiguous spectral unmixing. Unlimited numbers of biomarkers can be used in the assay system and can be co-localized with up to 12 markers, enabling the efficient testing of several hypotheses quickly and robustly. Ultivue’s technology has been used for diverse applications, including imaging of the tumor microenvironment. </p>


Ultivue

Find a biotech startup job.